Lung cancer in systemic lupus erythematosus

J. Bin, S. Bernatsky, C. Gordon, J. F. Boivin, E. Ginzler, D. Gladman, P. R. Fortin, M. Urowitz, S. Manzi, D. Isenberg, A. Rahman, Michelle Petri, O. Nived, G. Sturfeldt, R. Ramsey-Goldman, A. E. Clarke

Research output: Contribution to journalArticle

Abstract

Background: Evidence points to a link between systemic lupus erythematosus (SLE) and an increased risk of lung cancer. Our objective was to provide a brief report of the lung cancer cases from an SLE cohort, with respect to demographics, histology, and exposures to smoking and immunosuppressive medications. Methods: Data were obtained from a multi-site international cohort study of over 9500 SLE patients from 23 centres. Cancer cases were ascertained through linkage with regional tumor registries. Results: We analyzed information on histology subtype for 30 lung cancer cases that had occurred across five countries. Most (75%) of these 30 cases were female, with a median age of 61 (range 27-91) years. In eight cases, the histological type was not specified. In the remainder, the most common histological type reported was adenocarcinoma (N = 8; two of the adenocarcinomas were bronchoalveolar carcinoma) followed by small cell carcinoma (N = 6), and squamous cell carcinoma (N = 6) with one case each of large cell carcinoma and carcinoid tumor. Most (71%) of the lung cancer cases were smokers; only the minority (20%) had been previously exposed to immunosuppressive agents. Conclusions: The histological distribution of the lung cancers from the SLE sample appeared similar to that of lung cancer patients in the general population, though the possibility of a higher proportion of more uncommon tumors (such as bronchoalveolar and carcinoid) cannot be excluded. A large proportion of the cancer cases were smokers, which is also not surprising. However, only a minority appeared to have been exposed to immunosuppressive agents. A large case-cohort study currently in progress should help shed light on the relative importance of these exposures in lung cancer risk for SLE patients.

Original languageEnglish (US)
Pages (from-to)303-306
Number of pages4
JournalLung Cancer
Volume56
Issue number3
DOIs
StatePublished - Jun 2007

Fingerprint

Systemic Lupus Erythematosus
Lung Neoplasms
Immunosuppressive Agents
Carcinoid Tumor
Neoplasms
Histology
Adenocarcinoma
Cohort Studies
Large Cell Carcinoma
Small Cell Carcinoma
Registries
Squamous Cell Carcinoma
Smoking
Demography
Carcinoma
Population

Keywords

  • Lung cancer
  • SLE
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Oncology

Cite this

Bin, J., Bernatsky, S., Gordon, C., Boivin, J. F., Ginzler, E., Gladman, D., ... Clarke, A. E. (2007). Lung cancer in systemic lupus erythematosus. Lung Cancer, 56(3), 303-306. https://doi.org/10.1016/j.lungcan.2007.01.007

Lung cancer in systemic lupus erythematosus. / Bin, J.; Bernatsky, S.; Gordon, C.; Boivin, J. F.; Ginzler, E.; Gladman, D.; Fortin, P. R.; Urowitz, M.; Manzi, S.; Isenberg, D.; Rahman, A.; Petri, Michelle; Nived, O.; Sturfeldt, G.; Ramsey-Goldman, R.; Clarke, A. E.

In: Lung Cancer, Vol. 56, No. 3, 06.2007, p. 303-306.

Research output: Contribution to journalArticle

Bin, J, Bernatsky, S, Gordon, C, Boivin, JF, Ginzler, E, Gladman, D, Fortin, PR, Urowitz, M, Manzi, S, Isenberg, D, Rahman, A, Petri, M, Nived, O, Sturfeldt, G, Ramsey-Goldman, R & Clarke, AE 2007, 'Lung cancer in systemic lupus erythematosus', Lung Cancer, vol. 56, no. 3, pp. 303-306. https://doi.org/10.1016/j.lungcan.2007.01.007
Bin J, Bernatsky S, Gordon C, Boivin JF, Ginzler E, Gladman D et al. Lung cancer in systemic lupus erythematosus. Lung Cancer. 2007 Jun;56(3):303-306. https://doi.org/10.1016/j.lungcan.2007.01.007
Bin, J. ; Bernatsky, S. ; Gordon, C. ; Boivin, J. F. ; Ginzler, E. ; Gladman, D. ; Fortin, P. R. ; Urowitz, M. ; Manzi, S. ; Isenberg, D. ; Rahman, A. ; Petri, Michelle ; Nived, O. ; Sturfeldt, G. ; Ramsey-Goldman, R. ; Clarke, A. E. / Lung cancer in systemic lupus erythematosus. In: Lung Cancer. 2007 ; Vol. 56, No. 3. pp. 303-306.
@article{d386182a1a394b2aa0e398f751104fbb,
title = "Lung cancer in systemic lupus erythematosus",
abstract = "Background: Evidence points to a link between systemic lupus erythematosus (SLE) and an increased risk of lung cancer. Our objective was to provide a brief report of the lung cancer cases from an SLE cohort, with respect to demographics, histology, and exposures to smoking and immunosuppressive medications. Methods: Data were obtained from a multi-site international cohort study of over 9500 SLE patients from 23 centres. Cancer cases were ascertained through linkage with regional tumor registries. Results: We analyzed information on histology subtype for 30 lung cancer cases that had occurred across five countries. Most (75{\%}) of these 30 cases were female, with a median age of 61 (range 27-91) years. In eight cases, the histological type was not specified. In the remainder, the most common histological type reported was adenocarcinoma (N = 8; two of the adenocarcinomas were bronchoalveolar carcinoma) followed by small cell carcinoma (N = 6), and squamous cell carcinoma (N = 6) with one case each of large cell carcinoma and carcinoid tumor. Most (71{\%}) of the lung cancer cases were smokers; only the minority (20{\%}) had been previously exposed to immunosuppressive agents. Conclusions: The histological distribution of the lung cancers from the SLE sample appeared similar to that of lung cancer patients in the general population, though the possibility of a higher proportion of more uncommon tumors (such as bronchoalveolar and carcinoid) cannot be excluded. A large proportion of the cancer cases were smokers, which is also not surprising. However, only a minority appeared to have been exposed to immunosuppressive agents. A large case-cohort study currently in progress should help shed light on the relative importance of these exposures in lung cancer risk for SLE patients.",
keywords = "Lung cancer, SLE, Systemic lupus erythematosus",
author = "J. Bin and S. Bernatsky and C. Gordon and Boivin, {J. F.} and E. Ginzler and D. Gladman and Fortin, {P. R.} and M. Urowitz and S. Manzi and D. Isenberg and A. Rahman and Michelle Petri and O. Nived and G. Sturfeldt and R. Ramsey-Goldman and Clarke, {A. E.}",
year = "2007",
month = "6",
doi = "10.1016/j.lungcan.2007.01.007",
language = "English (US)",
volume = "56",
pages = "303--306",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Lung cancer in systemic lupus erythematosus

AU - Bin, J.

AU - Bernatsky, S.

AU - Gordon, C.

AU - Boivin, J. F.

AU - Ginzler, E.

AU - Gladman, D.

AU - Fortin, P. R.

AU - Urowitz, M.

AU - Manzi, S.

AU - Isenberg, D.

AU - Rahman, A.

AU - Petri, Michelle

AU - Nived, O.

AU - Sturfeldt, G.

AU - Ramsey-Goldman, R.

AU - Clarke, A. E.

PY - 2007/6

Y1 - 2007/6

N2 - Background: Evidence points to a link between systemic lupus erythematosus (SLE) and an increased risk of lung cancer. Our objective was to provide a brief report of the lung cancer cases from an SLE cohort, with respect to demographics, histology, and exposures to smoking and immunosuppressive medications. Methods: Data were obtained from a multi-site international cohort study of over 9500 SLE patients from 23 centres. Cancer cases were ascertained through linkage with regional tumor registries. Results: We analyzed information on histology subtype for 30 lung cancer cases that had occurred across five countries. Most (75%) of these 30 cases were female, with a median age of 61 (range 27-91) years. In eight cases, the histological type was not specified. In the remainder, the most common histological type reported was adenocarcinoma (N = 8; two of the adenocarcinomas were bronchoalveolar carcinoma) followed by small cell carcinoma (N = 6), and squamous cell carcinoma (N = 6) with one case each of large cell carcinoma and carcinoid tumor. Most (71%) of the lung cancer cases were smokers; only the minority (20%) had been previously exposed to immunosuppressive agents. Conclusions: The histological distribution of the lung cancers from the SLE sample appeared similar to that of lung cancer patients in the general population, though the possibility of a higher proportion of more uncommon tumors (such as bronchoalveolar and carcinoid) cannot be excluded. A large proportion of the cancer cases were smokers, which is also not surprising. However, only a minority appeared to have been exposed to immunosuppressive agents. A large case-cohort study currently in progress should help shed light on the relative importance of these exposures in lung cancer risk for SLE patients.

AB - Background: Evidence points to a link between systemic lupus erythematosus (SLE) and an increased risk of lung cancer. Our objective was to provide a brief report of the lung cancer cases from an SLE cohort, with respect to demographics, histology, and exposures to smoking and immunosuppressive medications. Methods: Data were obtained from a multi-site international cohort study of over 9500 SLE patients from 23 centres. Cancer cases were ascertained through linkage with regional tumor registries. Results: We analyzed information on histology subtype for 30 lung cancer cases that had occurred across five countries. Most (75%) of these 30 cases were female, with a median age of 61 (range 27-91) years. In eight cases, the histological type was not specified. In the remainder, the most common histological type reported was adenocarcinoma (N = 8; two of the adenocarcinomas were bronchoalveolar carcinoma) followed by small cell carcinoma (N = 6), and squamous cell carcinoma (N = 6) with one case each of large cell carcinoma and carcinoid tumor. Most (71%) of the lung cancer cases were smokers; only the minority (20%) had been previously exposed to immunosuppressive agents. Conclusions: The histological distribution of the lung cancers from the SLE sample appeared similar to that of lung cancer patients in the general population, though the possibility of a higher proportion of more uncommon tumors (such as bronchoalveolar and carcinoid) cannot be excluded. A large proportion of the cancer cases were smokers, which is also not surprising. However, only a minority appeared to have been exposed to immunosuppressive agents. A large case-cohort study currently in progress should help shed light on the relative importance of these exposures in lung cancer risk for SLE patients.

KW - Lung cancer

KW - SLE

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=34247574135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247574135&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2007.01.007

DO - 10.1016/j.lungcan.2007.01.007

M3 - Article

C2 - 17291624

AN - SCOPUS:34247574135

VL - 56

SP - 303

EP - 306

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 3

ER -